This site is intended for Healthcare professionals only.

CDC’s Guidelines for Syphilis


CDC’s Guidelines for Syphilis

Center for Disease Control and Prevention has come out with sexually transmitted diseases (STDs) treatment guidelines.These guidelines for the treatment of persons who have or are at risk for sexually transmitted diseases (STDs) were updated by CDC in 2015 after consultation with a group of professionals knowledgeable in the field of STDs who met in Atlanta on April 30–May 2, 2013.They have been prepared by the NNPTC, NCSD, and ASTDA, with support from the CDC division of STD prevention.

Center for Disease Control and Prevention Guidelines for Syphilis.

Primary, secondary, early latent (1 year) syphilis:

  • Recommended regimen:- Benzathine penicillin G, 2.4 million units IM once.*
  • Alternative oral regimens (penicillin-allergic, non pregnant women):- Doxycycline 100 mg orally twice daily for 2 weeks.

Late latent, tertiary, and cardiovascular syphilis:

  • Recommended regimen:- Benzathine penicillin G, 2.4 million units IM weekly times 3 doses.
  • Alternative oral regimen (penicillin-allergic, non pregnant women):- Doxycycline 100 mg orally twice daily for 4 weeks.**

Neurosyphilis^

  • Drugs of choice: Penicillin G 3 -4 million units IV every 4 hours or 24 million units continuous IV infusion for 10 – 14 days [or]
  • Penicillin G procaine 2.4 million units IM daily + probenecid 500 mg 4 times daily oral, both for 10 – 14 days
    Alternatives
  • ceftriaxone 2 g IV once daily for 10 – 14 days

Congenital

Drugs of choice: 

  • Penicillin G 50,000 units/kg every 8-12 hours for 10 -14 days [or]
  •  Penicillin G procaine 50,000 units/kg IM daily for 10 -14 days

* Some experts recommend a repeat dose after seven days, especially in patients with HIV infection or pregnant women.

**Not recommended in pregnancy.

^patients allergic to penicillin should be desensitized and treated with penicillin.

For Further Reference log on to :

http://www.ncsddc.org/resource/2015-cdc-std-treatment-guidelines-summary-chart/

The following two tabs change content below.
Anjali Nimesh

Anjali Nimesh

Anjali Nimesh Joined Medical Dialogue as Reporter in 2016. she covers all the medical specialty news in different medical categories. She also covers the Medical guidelines, Medical Journals, rare medical surgeries as well as all the updates in medical filed. She is a graduate from Dr. Bhimrao Ambedkar University. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751
Source: self

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted